Zhang Xinying, Chen Na, Ma Aihua, Wang Xueyu, Sun Wenxiu, Gao Yuxing
Medicine (Baltimore). 2018 Dec;97(51):e13749. doi: 10.1097/MD.0000000000013749.
Epilepsy with mental retardation limited to females (EFMR) is a rare type of X-linked epilepsy disorder, affecting heterozygous females disproportionately. The pathogenesis of EFMR has been identified as mutations in the protocadherin 19 (PCDH19) gene. To data, more than 60 different mutations in PCDH19 have been identified. Most of them are located at exon 1, but we describe a novel deletion mutation c.2468delT at exon 3 of PCDH19.
The patient was an 11-year-old girl with onset of seizures at the age of 18 months and followed by progressive intellectual disability (ID) later.
The girl was diagnosed as EFMR when a novel deletion mutation c.2468delT at exon 3 of PCDH19 was found. The deletion mutation c.2468delT was predicted to have caused a frameshift mutation of amino acid at position 823 (p.L823fs). There was no family history of seizures or ID. Her father was asymptomatic, but the mutation screening shows that he had a hemizygous mutation c.2468delT at the same site of PCDH19. The secondary structure of PCDH19 (wide type) showed that the sequences undergoing frameshift mutations were located in the cytoplasm and contain 9 phosphorylation sites. The p.L823fs mutation caused a totally different amino sequence after position of 823, thereby resulting in the disappearance of phosphorylation sites. The frameshift mutation of amino acid at position 823 might affect its binding capability with GABAA receptor and results in migration and morphological maturation of hippocampal neurons.
The patient has received antiepileptic treatments, including sodium valproate, carbamazepine, levetiracetam, topiramate and clonazepam et al. OUTCOMES:: The antiepileptic treatment effects were limited.
This case report describes a novel PCDH19 gene mutation (c.2468delT) at exon 3 in a girl suffering from EFMR. The deletion mutation was predicted to cause a frameshift mutation-p.L823fs, which is highly conserved across different species.
女性局限型智力发育迟缓的癫痫症(EFMR)是一种罕见的X连锁癫痫疾病,对杂合子女性的影响尤为严重。EFMR的发病机制已被确定为原钙黏蛋白19(PCDH19)基因突变。到目前为止,已在PCDH19中鉴定出60多种不同的突变。其中大多数位于第1外显子,但我们描述了一种位于PCDH19第3外显子的新型缺失突变c.2468delT。
该患者是一名11岁女孩,18个月大时开始出现癫痫发作,随后逐渐出现智力残疾(ID)。
当在PCDH19第3外显子发现新型缺失突变c.2468delT时,该女孩被诊断为EFMR。缺失突变c.2468delT预计会导致第823位氨基酸的移码突变(p.L823fs)。没有癫痫或智力残疾的家族史。她的父亲没有症状,但突变筛查显示他在PCDH19的同一位点有半合子突变c.2468delT。PCDH蛋白19(野生型)的二级结构显示,发生移码突变的序列位于细胞质中,包含9个磷酸化位点。p.L823fs突变导致823位之后的氨基酸序列完全不同,从而导致磷酸化位点消失。第823位氨基酸的移码突变可能会影响其与GABAA受体的结合能力,并导致海马神经元的迁移和形态成熟。
患者接受了抗癫痫治疗,包括丙戊酸钠、卡马西平、左乙拉西坦、托吡酯和氯硝西泮等。
抗癫痫治疗效果有限。
本病例报告描述了一名患有EFMR的女孩中PCDH19基因第3外显子的新型突变(c.2468delT)。该缺失突变预计会导致移码突变-p.L823fs,这在不同物种中高度保守。